Skip to main content

Table 1 Baseline characteristics

From: A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism

  Placebo (n = 19, 13 males, 6 females) Omega (n = 18, 14 males, 4 females)
  Mean (minimum-maximum) 95% CL for mean Mean (minimum-maximum) 95% CL for mean
Age (years) 3.5 (2.0 to 6.0) 3.0 to 4.0 3.9 (2.0 to 4.2) 3.4 to 4.4
ADOS     
  Communication (C) 5.5 (3.0 to 9.0) 4.6 to 6.5 5.5 (1.0 to 8.0) 4.6 to 6.5
  Social interaction (SI) 9.5 (6.0 to 14.0) 8.4 to 10.6 10.7 (4.0 to 14.0) 9.2 to 12.1
  Communication (C) + social interaction (SI) 15.0 (9.0 to 22.0) 13.1 to 16.9 15.2 (5.0 to 22.0) 12.5 to 17.9
ADI-R     
  Communication 17.2 (5.0 to 28.0) 14.3 to 20.1 19.4 (9.0 to 29.0) 16.7 to 22.2
  Social interaction 12.5 (7.0 to 23.0) 10.5 to 14.5 12.8 (9.0 to 20.0) 11.4 to 14.2
  Play 6.2 (2.0 to 10.0) 5.1 to 7.2 5.6 (2.0 to 10.0) 4.7 to 6.4
  Stereotyped behavior 4.1 (3.0 to 5.0) 3.7 to 4.5 4.1 (1.0 to 5.0) 3.6 to 4.6
Mullen scales of early learning-AGS     
  Visual reception 30.8 (20.0 to 63.0) 23.5 to 38.2 31.7 (19.0 to 65.0) 24.3 to 39.1
  Fine motor 28.3 (19.0 to 65.0) 21.9 to 34.6 23.6 (19.0 to 41.0) 20.2 to 27.1
  Receptive language 28.8 (19.0 to 56.0) 22.4 to 35.1 27.6 (19.0 to 62.0) 21.5 to 33.7
  Expressive language 26.8 (19.0 to 44.0) 22.8 to 30.8 25.7 (19.0 to 45.0) 21.2 to 30.3
  Blood omega levels 4.7 (3.4 to 6.2) 4.1 to 5.3 5.5 (3.9 to 8.2) 4.5 to 6.6